MXPA02000958A - Strategy for carbohydrate based cancer vaccines. - Google Patents

Strategy for carbohydrate based cancer vaccines.

Info

Publication number
MXPA02000958A
MXPA02000958A MXPA02000958A MXPA02000958A MXPA02000958A MX PA02000958 A MXPA02000958 A MX PA02000958A MX PA02000958 A MXPA02000958 A MX PA02000958A MX PA02000958 A MXPA02000958 A MX PA02000958A MX PA02000958 A MXPA02000958 A MX PA02000958A
Authority
MX
Mexico
Prior art keywords
strategy
cancer vaccines
based cancer
carbohydrate based
carbohydrate
Prior art date
Application number
MXPA02000958A
Other languages
Spanish (es)
Inventor
Harold J Jennings
Original Assignee
Ca Nat Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ca Nat Research Council filed Critical Ca Nat Research Council
Publication of MXPA02000958A publication Critical patent/MXPA02000958A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
MXPA02000958A 1999-07-29 2000-07-28 Strategy for carbohydrate based cancer vaccines. MXPA02000958A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002279134A CA2279134A1 (en) 1999-07-29 1999-07-29 Novel strategy for carbohydrate-based therapeutic vaccines
PCT/CA2000/000886 WO2001009298A2 (en) 1999-07-29 2000-07-28 Strategy for carbohydrate-based cancer vaccines

Publications (1)

Publication Number Publication Date
MXPA02000958A true MXPA02000958A (en) 2003-07-21

Family

ID=4163882

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02000958A MXPA02000958A (en) 1999-07-29 2000-07-28 Strategy for carbohydrate based cancer vaccines.

Country Status (8)

Country Link
EP (1) EP1198244A2 (en)
JP (1) JP2003506034A (en)
AU (1) AU6420000A (en)
CA (1) CA2279134A1 (en)
IL (1) IL147776A0 (en)
MX (1) MXPA02000958A (en)
WO (1) WO2001009298A2 (en)
ZA (1) ZA200200731B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040009195A1 (en) * 2000-07-28 2004-01-15 Jennings Harold J Modified sialic acid vaccines
EP1293212A1 (en) * 2001-08-21 2003-03-19 National Research Council Of Canada Anti cancer vaccine comprising whole cancer cells with modified sialic acid
AU2005258301A1 (en) 2004-06-23 2006-01-05 Children's Hospital & Research Center At Oakland Polysaccharide derivatives and uses in induction of an immune response
US8148335B2 (en) 2004-06-23 2012-04-03 Children's Hospital & Research Center Oakland De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
JP5384941B2 (en) * 2005-12-23 2014-01-08 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド Deacetylated sialic acid antigens, antibodies thereto, and methods of use in cancer therapy.
WO2007116409A2 (en) 2006-04-11 2007-10-18 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Improved vaccines comprising multimeric hsp60 peptide carriers
CA2690440A1 (en) 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Oligosialic acid derivatives, methods of manufacture, and immunological uses
AU2008272785B2 (en) 2007-07-03 2014-06-12 Children's Hospital & Research Center At Oakland Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
JP5597130B2 (en) * 2007-07-03 2014-10-01 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド Inhibitors of polysialic acid de-N-acetylase and methods of use thereof
US8640245B2 (en) 2010-12-24 2014-01-28 Kaspersky Lab, Zao Optimization of anti-malware processing by automated correction of detection rules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102663A (en) * 1988-10-18 1992-04-07 Sloan-Kettering Instutute For Cancer Research Vaccine for stimulating or enhancing production of antibodies against 9-O-acetyl GD3
US5811102A (en) * 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines

Also Published As

Publication number Publication date
IL147776A0 (en) 2002-08-14
ZA200200731B (en) 2003-03-26
EP1198244A2 (en) 2002-04-24
CA2279134A1 (en) 2001-01-29
JP2003506034A (en) 2003-02-18
AU6420000A (en) 2001-02-19
WO2001009298A2 (en) 2001-02-08
WO2001009298A3 (en) 2001-08-23

Similar Documents

Publication Publication Date Title
HK1047942A1 (en) Purine derivatives.
MXPA01013362A (en) ANTI-alphav.
ZA200110208B (en) Purine derivatives.
HK1047110A1 (en) Purine derivatives.
ZA200201055B (en) Amino-triazolopyridine derivatives.
HK1048642A1 (en) Fap-activated anti-tumor compounds.
EG24361A (en) 4-pyrimiding1-n-acy1.l.phenlalanines
PL351486A1 (en) Prrsv vaccines
ZA200202537B (en) Pour-on-formulations.
ZA200109595B (en) 13-methyl-erythromycin derivatives.
HK1046411A1 (en) 5-Phenyl-pyrimidine derivatives.
HK1053470A1 (en) 4-Pyridinyln-acyl-l-phenylalanines.
ZA200006352B (en) Compound napkin.
HK1029502A1 (en) Slider-pull-assembling unit.
ZA200107346B (en) Erythromycin derivatives.
MXPA02000958A (en) Strategy for carbohydrate based cancer vaccines.
ZA200108489B (en) Tampon.
GB9901254D0 (en) Vaccines
ZA200201276B (en) 3-Amino-2-phenyl-propane derivatives.
ZA200110454B (en) Pharmaceutical complex.
MXPA01011285A (en) Thio-oxindole derivatives.
HK1032679A1 (en) Connector.
MXPA01010701A (en) Vaccine.
ZA200204581B (en) Nitro-sulfobenzamides.
HK1031254A1 (en) Tachogragh.